Global Biopharmaceutical Characterization Service Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02256526

Publication Date:

March 3, 2025

Pages:

107

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Biopharmaceutical Characterization Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Biopharmaceutical characterization service refers to a range of analytical techniques and services used to assess the quality, safety, and efficacy of biopharmaceutical products. These services are typically offered by specialized contract research organizations (CROs) or analytical laboratories.
Biopharmaceutical characterization involves the detailed analysis of various attributes of a biopharmaceutical product, including its chemical composition, physical properties, stability, impurity profile, and biological activity. This characterization is crucial for ensuring the quality and consistency of biopharmaceutical products throughout their development, manufacturing, and regulatory approval processes.
Some common techniques used in biopharmaceutical characterization include:
1. Mass spectrometry: Used to identify and quantify the protein or peptide components of a biopharmaceutical product, as well as detect any modifications or impurities.
2. Chromatography: Various chromatographic techniques, such as high-performance liquid chromatography (HPLC) or size-exclusion chromatography (SEC), are used to separate and analyze the components of a biopharmaceutical product.
3. Spectroscopy: Techniques like nuclear magnetic resonance (NMR) spectroscopy or infrared (IR) spectroscopy are used to analyze the chemical structure and composition of biopharmaceuticals.
4. Bioassays: These are biological tests used to assess the biological activity and potency of a biopharmaceutical product. Examples include cell-based assays or enzyme activity assays.
5. Particle analysis: Techniques like dynamic light scattering (DLS) or microscopy are used to analyze the size, shape, and aggregation state of particles in biopharmaceutical formulations.
Biopharmaceutical characterization services are essential for ensuring the safety, efficacy, and regulatory compliance of biopharmaceutical products. They help pharmaceutical companies and researchers understand the critical quality attributes of their products, optimize their manufacturing processes, and meet regulatory requirements.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淏iopharmaceutical Characterization Service Industry Forecast鈥� looks at past sales and reviews total world Biopharmaceutical Characterization Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical Characterization Service sales for 2025 through 2031. With Biopharmaceutical Characterization Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical Characterization Service industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical Characterization Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical Characterization Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Biopharmaceutical Characterization Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical Characterization Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical Characterization Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Characterization Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Protein Analysis
Peptide Analysis
Segmentation by Application:
Enterprise
Research Institute
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SGS
Alfa Chemistry
Intertek
Eurofins Scientific
Solvias
Center for Biopharma Analysis
Bioneeds
Vproteomics
Cambrex
Merck
Drug Development Solutions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharmaceutical Characterization Service Market Size (2020-2031)
2.1.2 Biopharmaceutical Characterization Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Biopharmaceutical Characterization Service by Country/Region (2020, 2024 & 2031)
2.2 Biopharmaceutical Characterization Service Segment by Type
2.2.1 Protein Analysis
2.2.2 Peptide Analysis
2.3 Biopharmaceutical Characterization Service Market Size by Type
2.3.1 Biopharmaceutical Characterization Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Biopharmaceutical Characterization Service Market Size Market Share by Type (2020-2025)
2.4 Biopharmaceutical Characterization Service Segment by Application
2.4.1 Enterprise
2.4.2 Research Institute
2.5 Biopharmaceutical Characterization Service Market Size by Application
2.5.1 Biopharmaceutical Characterization Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Biopharmaceutical Characterization Service Market Size Market Share by Application (2020-2025)
3 Biopharmaceutical Characterization Service Market Size by Player
3.1 Biopharmaceutical Characterization Service Market Size Market Share by Player
3.1.1 Global Biopharmaceutical Characterization Service Revenue by Player (2020-2025)
3.1.2 Global Biopharmaceutical Characterization Service Revenue Market Share by Player (2020-2025)
3.2 Global Biopharmaceutical Characterization Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biopharmaceutical Characterization Service by Region
4.1 Biopharmaceutical Characterization Service Market Size by Region (2020-2025)
4.2 Global Biopharmaceutical Characterization Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biopharmaceutical Characterization Service Market Size Growth (2020-2025)
4.4 APAC Biopharmaceutical Characterization Service Market Size Growth (2020-2025)
4.5 Europe Biopharmaceutical Characterization Service Market Size Growth (2020-2025)
4.6 Middle East & Africa Biopharmaceutical Characterization Service Market Size Growth (2020-2025)
5 Americas
5.1 Americas Biopharmaceutical Characterization Service Market Size by Country (2020-2025)
5.2 Americas Biopharmaceutical Characterization Service Market Size by Type (2020-2025)
5.3 Americas Biopharmaceutical Characterization Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical Characterization Service Market Size by Region (2020-2025)
6.2 APAC Biopharmaceutical Characterization Service Market Size by Type (2020-2025)
6.3 APAC Biopharmaceutical Characterization Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biopharmaceutical Characterization Service Market Size by Country (2020-2025)
7.2 Europe Biopharmaceutical Characterization Service Market Size by Type (2020-2025)
7.3 Europe Biopharmaceutical Characterization Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biopharmaceutical Characterization Service by Region (2020-2025)
8.2 Middle East & Africa Biopharmaceutical Characterization Service Market Size by Type (2020-2025)
8.3 Middle East & Africa Biopharmaceutical Characterization Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biopharmaceutical Characterization Service Market Forecast
10.1 Global Biopharmaceutical Characterization Service Forecast by Region (2026-2031)
10.1.1 Global Biopharmaceutical Characterization Service Forecast by Region (2026-2031)
10.1.2 Americas Biopharmaceutical Characterization Service Forecast
10.1.3 APAC Biopharmaceutical Characterization Service Forecast
10.1.4 Europe Biopharmaceutical Characterization Service Forecast
10.1.5 Middle East & Africa Biopharmaceutical Characterization Service Forecast
10.2 Americas Biopharmaceutical Characterization Service Forecast by Country (2026-2031)
10.2.1 United States Market Biopharmaceutical Characterization Service Forecast
10.2.2 Canada Market Biopharmaceutical Characterization Service Forecast
10.2.3 Mexico Market Biopharmaceutical Characterization Service Forecast
10.2.4 Brazil Market Biopharmaceutical Characterization Service Forecast
10.3 APAC Biopharmaceutical Characterization Service Forecast by Region (2026-2031)
10.3.1 China Biopharmaceutical Characterization Service Market Forecast
10.3.2 Japan Market Biopharmaceutical Characterization Service Forecast
10.3.3 Korea Market Biopharmaceutical Characterization Service Forecast
10.3.4 Southeast Asia Market Biopharmaceutical Characterization Service Forecast
10.3.5 India Market Biopharmaceutical Characterization Service Forecast
10.3.6 Australia Market Biopharmaceutical Characterization Service Forecast
10.4 Europe Biopharmaceutical Characterization Service Forecast by Country (2026-2031)
10.4.1 Germany Market Biopharmaceutical Characterization Service Forecast
10.4.2 France Market Biopharmaceutical Characterization Service Forecast
10.4.3 UK Market Biopharmaceutical Characterization Service Forecast
10.4.4 Italy Market Biopharmaceutical Characterization Service Forecast
10.4.5 Russia Market Biopharmaceutical Characterization Service Forecast
10.5 Middle East & Africa Biopharmaceutical Characterization Service Forecast by Region (2026-2031)
10.5.1 Egypt Market Biopharmaceutical Characterization Service Forecast
10.5.2 South Africa Market Biopharmaceutical Characterization Service Forecast
10.5.3 Israel Market Biopharmaceutical Characterization Service Forecast
10.5.4 Turkey Market Biopharmaceutical Characterization Service Forecast
10.6 Global Biopharmaceutical Characterization Service Forecast by Type (2026-2031)
10.7 Global Biopharmaceutical Characterization Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Biopharmaceutical Characterization Service Forecast
11 Key Players Analysis
11.1 SGS
11.1.1 SGS Company Information
11.1.2 SGS Biopharmaceutical Characterization Service Product Offered
11.1.3 SGS Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 SGS Main Business Overview
11.1.5 SGS Latest Developments
11.2 Alfa Chemistry
11.2.1 Alfa Chemistry Company Information
11.2.2 Alfa Chemistry Biopharmaceutical Characterization Service Product Offered
11.2.3 Alfa Chemistry Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Alfa Chemistry Main Business Overview
11.2.5 Alfa Chemistry Latest Developments
11.3 Intertek
11.3.1 Intertek Company Information
11.3.2 Intertek Biopharmaceutical Characterization Service Product Offered
11.3.3 Intertek Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Intertek Main Business Overview
11.3.5 Intertek Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Biopharmaceutical Characterization Service Product Offered
11.4.3 Eurofins Scientific Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 Solvias
11.5.1 Solvias Company Information
11.5.2 Solvias Biopharmaceutical Characterization Service Product Offered
11.5.3 Solvias Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Solvias Main Business Overview
11.5.5 Solvias Latest Developments
11.6 Center for Biopharma Analysis
11.6.1 Center for Biopharma Analysis Company Information
11.6.2 Center for Biopharma Analysis Biopharmaceutical Characterization Service Product Offered
11.6.3 Center for Biopharma Analysis Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Center for Biopharma Analysis Main Business Overview
11.6.5 Center for Biopharma Analysis Latest Developments
11.7 Bioneeds
11.7.1 Bioneeds Company Information
11.7.2 Bioneeds Biopharmaceutical Characterization Service Product Offered
11.7.3 Bioneeds Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bioneeds Main Business Overview
11.7.5 Bioneeds Latest Developments
11.8 Vproteomics
11.8.1 Vproteomics Company Information
11.8.2 Vproteomics Biopharmaceutical Characterization Service Product Offered
11.8.3 Vproteomics Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Vproteomics Main Business Overview
11.8.5 Vproteomics Latest Developments
11.9 Cambrex
11.9.1 Cambrex Company Information
11.9.2 Cambrex Biopharmaceutical Characterization Service Product Offered
11.9.3 Cambrex Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cambrex Main Business Overview
11.9.5 Cambrex Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Biopharmaceutical Characterization Service Product Offered
11.10.3 Merck Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Drug Development Solutions
11.11.1 Drug Development Solutions Company Information
11.11.2 Drug Development Solutions Biopharmaceutical Characterization Service Product Offered
11.11.3 Drug Development Solutions Biopharmaceutical Characterization Service Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Drug Development Solutions Main Business Overview
11.11.5 Drug Development Solutions Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂